icon
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
icon Mon 19 Oct 2026
Beta version
icon
Official Saudi government website domains end with gov.sa

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

icon
Official Reliable websites use HTTPS

Ensure the website is using the HTTPS protocol.

icon

Registered with the Digital Government Authority under number:

20250831619
Suggestions

News

sdcsdc
icon 2025-12-16

SFDA Academy Delivers Specialized Training on Clinical Evaluation for Vaccine and Biologics Registration to Gulf Health Council

The Saudi Food and Drug Authority (SFDA), through its educational arm, the Food and Drug Academy, and in cooperation with the SFDA Drug Sector...
More
d
icon 2025-12-14

SFDA Leads Digital Transformation in Drug and Cosmetic Safety Regulation

The Saudi Food and Drug Authority (SFDA) continues to advance a new phase of regulatory innovation through comprehensive digital transformation...
More
vs
icon 2025-12-14

SFDA CEO Meets with Industry Leaders and Citizens in Jeddah

The CEO of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, held a meeting today, Sunday, with several presidents and...
More
253
icon 2025-12-11

SFDA to Organize Generic Drug Conference to Empower Local Pharmaceutical Manufacturing on December 30

The Saudi Food and Drug Authority (SFDA) is organizing a Generic Drug Conference, titled "Empowering Local Pharmaceutical Manufacturing: The Future of...
More
4645
icon 2025-12-04

SFDA: Significant Expansion in Feed Products with 60% Growth in First Half of 2025

The Saudi Food and Drug Authority (SFDA) announced a 60% increase in the availability of feed products in the Kingdom of Saudi Arabia during the first...
More
4564
icon 2025-12-01

Global Leadership for Increasing Patient Accessibility, SFDA Expands Lojuxta Indication to Include Treatment of Children with Homozygous Familial Hypercholesterolemia (HoFH)

The Saudi Food and Drug Authority (SFDA) announced its approval of a new medical claim for Lojuxta (lomitapide), allowing its use to treat children...
More